Objective: Preeclampsia a hypertensive disorder of pregnancy that mainly manifests as high blood pressure and proteinuria. Angiotensinogen (AGT) plays important roles in the regulation of blood pressure. The purpose of this study was to investigate the relationship between AGT M235T polymorphism and risk of preeclampsia using a meta-analysis. Methods: In this meta-analysis, 22 studies were selected by searching PubMed, EMBASE, ISI and CNKI databases up to October 2011. Crude odds ratios with corresponding 95% confidence intervals were used to evaluate the association between the AGT M235T polymorphism and risk of preeclampsia. Subgroup analyses were conducted by ethnicity and parity. Results: The TT genotype of the AGT M235T polymorphism was associated with elevated risk of preeclampsia in the overall analysis. In subgroup analysis according to ethnicity, increased risks were also found in Caucasians. After stratification based on parity, the excess risk was found in multigravida. Conclusions: These results showed that the TT genotype may play critical roles in the development of preeclampsia.
Introduction
Preeclampsia (PE) is a hypertensive disorder of pregnancy. This disease manifests as high blood pressure and proteinuria, may affect multiple systems of the body and contribute to adverse pregnancy outcomes including maternal death, preterm birth, fetal intrauterine growth restriction and fetal death. According to the 2005 World Health Organization report, PE occurs in approximately 3-5% of pregnancies worldwide. 1 PE/eclampsia leads to 10-15% of direct maternal deaths, and the incidence is higher in developing countries than in developed countries. 2 Although the etiology of PE is still unclear, its familial nature has been demonstrated. First-degree relatives of preeclamptic women were shown to have higher rates of getting PE than matched controls regardless of populations. 3 To clarify the genetic nature of PE, a range of studies have been conducted to investigate the linkage between genes (e.g. angiotensinogen) and PE.
Angiotensinogen (AGT) is the precursor of angiotensin II, that plays crucial roles in the regulation of blood pressure. The AGT gene, located on chromosome 1, has been reported to be related to the development of PE and essential hypertension. [4] [5] [6] A common polymorphism AGT M235T (the substitution of threonine [Thr] for methionine [Met] at codon 235) was first identified in 1992, 7 and the Thr235 variant has been reported to be associated with higher AGT levels and abnormal remodeling of the uterine spiral arteries, which is an early cause of PE. [8] [9] [10] To date, large numbers of epidemiological studies have been performed to examine the relationship between the AGT M235T polymorphism and risk of PE. 8, [11] [12] [13] [14] [15] [16] The results, however, were controversial in different studies. Some investigators reported that the AGT M235T polymorphism was associated with the risk of PE in Caucasian 5, 17, 18 and Japanese patients. 19 In contrast, other investigators have reported that the AGT M235T polymorphism was not a risk factor for the development of PE in Africans, 20 Asians, [21] [22] [23] [24] and Caucasians. [25] [26] [27] We have conducted a meta-analysis to provide strong evidence of the effects of the AGT M235T polymorphism on PE risk, with much greater sample size.
Materials and methods

Selection of published studies
We searched all publications of PubMed, EMBASE, ISI Web of Science and CNKI databases via the internet without language limitation. The following terms were used as searching keywords: [("polymorphism" or "polymorphisms" or "variant") and ("AGT" or "angiotensinogen") and ("pre-eclampsia" or "preeclampsia")]. The literature search was performed up to October 2011. Two authors (Ni and Zhang) conducted the retrieval work independently.
The inclusion criteria were: (a) case-control and casecohort studies that explored the association between the AGT M235T polymorphism and risk of PE/eclampsia; (b) presenting original data for the calculation of odds ratios (ORs) with corresponding 95% confidence intervals (95%CIs). We excluded studies with smaller sample size if duplicate publications were reported by the same group.
The definition of PE was described as following the criteria according to the report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. 28 Women with eclampsia and hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome were included.
Data extraction
Two authors (Ni and Zhang) extracted data from the selected studies independently. If the data they obtained were different, the third author (Zhou) would check the data and a final decision would be made following discussion among the three authors. The following information was collected from each study: the surname of the first author; country; year of publication; study design; ethnicity; matching variables; population evaluated; number of cases and controls; genotyping methods; quality control for genotyping assay; allele frequencies and genotype distribution in cases and controls (if the data were not available, we computed according to the corresponding genotyping frequencies).
Statistical analysis
ORs with corresponding 95% CIs were used to assess the effect of the AGT M235T polymorphism on PE risk (MT versus MM, TT versus MM, TT versus MM/MT, and MT/ TT versus MM). We evaluated the between-study heterogeneity first using the Q-test and I 2 statistics. 29, 30 If the p-value for the Q-test was >0.10 and I 2 <50%, the fixed-effects model (the Mantel-Haenszel method) was carried out to estimate the summarized ORs. On the contrary, if the p-value for the Q-test was ≤0.10 or I 2 ≥50%, the randomeffects model (the DerSimonian and Laird method) was carried out to estimate the summarized ORs, and logistic meta-regression was used to investigate potential sources of heterogeneity across studies. Subgroup analyses were conducted based on ethnicity (Asian, Caucasian, African and mixed) and parity (primiparity versus multiparity). Funnel plot and Egger's regression asymmetry test were performed to assess publication bias. All analyses were done in STATA software, version 10.0 (STATA Corp., College Station, TX, USA).
Results
Characteristics of studies
In total, 236 articles were found after searching the databases mentioned above; 135 duplicated articles were excluded, leaving 101 studies. Of these, 44 studies were excluded after screening the title or abstract (13 were not the AGT M235T polymorphism; 23 were not preeclampsia; five were review articles; and no data were available in three). After retrieving the full-text articles, 35 were excluded (eight were not preeclampsia; six were not the AGT M235T polymorphism; five were review articles; 15 were no available data and one was overlapped data). Finally, 22 studies were selected in this meta-analysis with 2367 cases and 5167 controls ( Figure 1 ; Table 1 ). Since the genotype distributions were presented in different populations in three studies, they were considered separately in subgroup analysis according to ethnicity. 5, 15, 21 There were 10 studies in Asians, 11 studies in Caucasians, two studies in Africans, and two studies in mixed populations containing more than one ethnicity.
Several genotyping methods were used, such as allelespecific oligonucleotide hybridization, allele-specific amplification, polymerase chain reaction-restriction fragment length polymorphism and Taqman assay. Only nine studies, however, reported quality control for genotyping assay, including positive control, negative control, random replication and sequencing. The genotype distributions in controls were consistent with Hardy-Weinberg equilibrium (HWE) in all except three studies. 8, 26, 27 
Main results
The TT genotype of the AGT M235T polymorphism was associated with a significantly increased risk of PE in overall analysis (TT versus MM: OR=1.33, 95%CI, 1.09-1.61; TT versus MM/MT: OR=1.30, 95%CI, 1.02-1.67, respectively). In subgroup analysis according to ethnicity, significantly increased risks were also found in Caucasians (MT versus MM: OR=1.32, 95%CI, 1.08-1.62; TT versus MM: OR=1.43, 95%CI, 1.12-1.83; TT versus MM/MT: OR=1.25, 95%CI, 1.02-1.54; and MT/ TT versus MM: OR=1.36, 95%CI, 1.12-1.64, respectively) but not in Africans, Asians and mixed populations (Figures 2 and 3 ). After stratification based on parity, the excess risk was found in multigravida (TT versus MM/ MT: OR=1.95; 95%CI, 1.10-3.47) but not in primigravida ( Table 2 ).
Heterogeneity analysis and publication bias
Obvious heterogeneity between studies was present in the overall comparisons (TT versus MM/MT: p<0.001). Meta-regression analysis was used to explore the sources of the heterogeneity. However, none of the predetermined potential sources (ethnicity, genotyping methods, sample size, and HWE) could account for the heterogeneity. Funnel plot and Egger's regression asymmetry test were used to estimate publication bias, and we failed to find any bias in all comparisons.
Discussion
In this meta-analysis, 22 studies with 2367 cases and 5167 controls were selected, and the TT genotype of the AGT M235T polymorphism was found to be associated with an increased risk of PE. Similar positive results were also observed in Caucasians and multigravida women. Our results were in consistent with previous meta-analyses. In 2007, Medica et al. performed a metaanalysis involving 13 studies with 1128 patients and 2278 controls, and found that the TT genotype had a 1.54-fold risk of developing PE compared with the MM/ MT genotypes under a random-effects model (OR=1.54, 95%CI, 1.12-2.11). 31 In 2008, Zafarmand et al. performed another meta-analysis involving 17 studies with 1446 patients and 3829 controls, and found that women carrying the TT genotype were 62% more likely to develop PE compared with those carrying the MM genotype (OR=1.62, 95%CI, 1.12-2.33). 32 These findings indicate that AGT may be a candidate susceptibility gene in the development of PE.
Subgroup analysis according to ethnicity showed that the excess risk of the AGT M235T polymorphism was found in Caucasians but not in Africans, Asians and mixed populations. This result was similar to the report by Zafarmand et al., who found that the TT genotype of the AGT M235T polymorphism was significantly associated with a high risk of PE in Caucasians but not in Hispanics or Black Africans. 32 association is marginal. Moreover, the sample size is relatively small, and may not provide enough statistical power to detect the effect of the AGT M235T polymorphism on PE risk, particularly in Africans, with only 409 cases and 540 controls eligible in this meta-analysis. Therefore, further studies with larger population samples are necessary to confirm these findings.
Emerging evidence has shown that the pathophysiology of PE is different in primigravida and multigravida. 33, 34 Therefore, subgroup analysis based on parity was also conducted. We found that the TT genotype of the AGT M235T polymorphism was more likely to develop PE in multigravida rather than in primigravida. AGT is one of the key effectors in the regulation of blood pressure. Multigravida with PE had an earlier increase in blood pressure than primigravida, 34 which may contribute to the positive result of the AGT M235T polymorphism in multigravida. Replication association studies would be of great value to verify this result because of the very limited sample size in this study.
Although the exact mechanism of PE remains unclear, it is widely accepted that AGT plays critical roles in its development. AGT is a renin substrate, which is a major molecule in the renin-angiotensin-aldosterone system (RAAS), with the function of regulating blood pressure. The AGT levels among hypertensive individuals are related to the variants of AGT gene. 7 AGT 235T expression was elevated in decidual spiral arteries, and the T allele was associated with abnormal pregnancy-induced spiral artery remodeling, which caused atherotic changes and promoted the cascade of events resulting in PE. 9, 35 Taken together, our findings that the AGT may be a risk factor for the development of PE are biologically plausible. There are some limitations in our study. The obvious heterogeneity among studies was detected in one of the overall comparison models (TT versus MM/MT). Several possible variables including ethnicity, genotyping methods, sample size, and HWE were taken into consideration to account for the heterogeneity. However, none of these factors could explain this variation, suggesting unknown reasons may have biased the result. On the other hand, detailed information on the gene-gene and gene-environment interactions was not available, which may influence our comprehensive understanding about the genetic susceptibility to PE. Although these limitations existed in this study, no evidence of publication bias was present, indicating our results were reliable in methodology.
To conclude, this meta-analysis provides strong evidence that women carrying the TT genotype of the AGT M235T polymorphism had an elevated risk of developing PE, particularly in Caucasians and multiparous women. Further validation is warranted to determine the association in diverse ethnic groups. In addition, understanding the combination of genetic factors together with environmental exposures will increase our understanding of the etiology of PE. 
